Staphylococcus aureus develops an alternative, ica-independent biofilm in the absence of the arlRS two-component system by Toledo Arana, Alejandro et al.
JOURNAL OF BACTERIOLOGY, Aug. 2005, p. 5318–5329 Vol. 187, No. 15
0021-9193/05/$08.000 doi:10.1128/JB.187.15.5318–5329.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Staphylococcus aureus Develops an Alternative, ica-Independent
Biofilm in the Absence of the arlRS Two-Component System†
Alejandro Toledo-Arana,1 Nekane Merino,1 Marta Vergara-Irigaray,1 Michel De´barbouille´,2
Jose´ R. Penade´s,3 and In˜igo Lasa1*
Laboratory of Microbial Biofilms, Instituto de Agrobiotecnologı´a and Departamento de Produccio´n Agraria,
Universidad Pu´blica de Navarra-CSIC, Pamplona-31006, Spain1; Biologie des Bacte´ries pathoge`nes a`
Gram positif, De´partement de Microbiologie Fondamentale et Medı´cale (CNRS, URA 2172),
Institut Pasteur, Paris 75724, France2; and Cardenal Herrera-CEU University and
Instituto Valenciano de Investigaciones Agrarias (IVIA),
46113 Moncada, Valencia, Spain3
Received 18 March 2005/Accepted 28 April 2005
The biofilm formation capacity of Staphylococcus aureus clinical isolates is considered an important virulence
factor for the establishment of chronic infections. Environmental conditions affect the biofilm formation
capacity of S. aureus, indicating the existence of positive and negative regulators of the process. The majority
of the screening procedures for identifying genes involved in biofilm development have been focused on genes
whose presence is essential for the process. In this report, we have used random transposon mutagenesis and
systematic disruption of all S. aureus two-component systems to identify negative regulators of S. aureus biofilm
development in a chemically defined medium (Hussain-Hastings-White modified medium [HHWm]). The
results of both approaches coincided in that they identified arlRS as a repressor of biofilm development under
both steady-state and flow conditions. The arlRS mutant exhibited an increased initial attachment as well as
increased accumulation of poly-N-acetylglucosamine (PNAG). However, the biofilm formation of the arlRS
mutant was not affected when the icaADBC operon was deleted, indicating that PNAG is not an essential
compound of the biofilm matrix produced in HHWm. Disruption of the major autolysin gene, atl, did not
produce any effect on the biofilm phenotype of an arlRS mutant. Epistatic experiments with global regulators
involved in staphylococcal-biofilm formation indicated that sarA deletion abolished, whereas agr deletion
reinforced, the biofilm development promoted by the arlRS mutation.
Staphylococcus aureus is a gram-positive bacterium respon-
sible for many infections ranging from folliculitis and food-
borne intoxications to severe endocarditis, osteomyelitis, or
septicemia. S. aureus can live harmlessly on many skin surfaces,
especially around the nose, mouth, genitals, and rectum. This
organism shares with other pathogens the ability to adhere to
catheters and other indwelling devices and form multicellular
communities embedded in an exopolysaccharidic matrix
known as a biofilm (for reviews, see references 22 and 11).
Inside the biofilm, S. aureus becomes more resistant to antibi-
otic treatments and the actions of the immune system (2, 23).
As a consequence, staphylococcal-biofilm-associated infections
of this type are difficult to eradicate, and most of them can be
eliminated only by the removal and substitution of the con-
taminated implant.
With the exception of the icaADBC operon, discovered by
heterologous complementation of a biofilm-negative Staphylo-
coccus carnosus isolate with a genomic library of Staphylococ-
cus epidermidis RP62A (29), early genetic studies of the staph-
ylococcal-biofilm formation process have been performed
using transposon mutagenesis on a biofilm-positive isolate and
the ensuing selection of biofilm-deficient mutants by a micro-
titer plate assay (6, 13, 24, 27, 28, 37, 38, 42, 46, 49). These
studies have been crucial for identifying S. aureus genes whose
presence is essential for primary attachment and/or biofilm
development under the environmental conditions used during
the screening process. However, this approach, based on the
selection of biofilm-deficient mutants, biased the screening in
favor of those genes that encode products that are required for
the biofilm development process, either because their enzy-
matic activities are required for the synthesis of compounds of
the biofilm matrix, because they are themselves compounds of
the matrix, or simply because they play a positive regulatory
role in the process. As regards the regulatory genes, a lot of
evidence suggests the presence of negative regulatory mecha-
nisms in the expression of the product of the icaADBC operon,
the extracellular poly-N-acetylglucosamine (PNAG) polysac-
charide, and consequently on the formation of a biofilm. First,
icaR, located adjacent to the ica operon, encodes a transcrip-
tional repressor involved in the environmental regulation of ica
operon expression both in S. aureus (33) and in S. epidermidis
(10). Second, TcaR, a transcriptional regulator of the teicopla-
nin-associated locus, has very recently been described as a
negative regulator of ica operon transcription, though deletion
of tcaR alone did not induce changes in PNAG production and
adherence to polystyrene (33). Third, strong biofilm develop-
ment can be induced when Trypticase soy broth (TSB) medium
is supplemented with 0.5 M of NaCl, indicating that NaCl
either induces or derepresses the expression of biofilm genes
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(45, 49). In this regard, the capacity of S. aureus to produce a
biofilm is dependent on the environmental conditions, which
suggests that there is a mechanism that senses and responds to
environmental signals. Two-component systems (TCS) are
common signal transduction mechanisms used by bacteria to
modulate gene expression in response to a variety of stimuli.
To date, only two TCS of S. aureus, agr and arlRS, have been
related to biofilm formation. As regards agr, an epidemiolog-
ical study demonstrated that agr mutants of S. aureus can
frequently be isolated and that these mutants exhibit an en-
hanced attachment to polystyrene compared to that of agr-
positive isolates (51). In the case of arlRS, it has been reported
that an arlS transposon mutant, isolated according to its in-
creased resistance to tetraphenylphosphonium bromide, dis-
played an enhanced capacity to form biofilms, but the mecha-
nism responsible for this enhancement was not determined
(18).
This study has identified those genes whose expression re-
pressed the biofilm formation process in a chemically defined
medium (Hussain-Hastings-White modified medium [HHWm]).
For that identification, we have used systematic mutagenesis of
two-component systems and random transposon mutagenesis
in combination with screening for biofilm-positive mutants.
The results revealed that the deletion of the arlRS two-com-
ponent system bestows on S. aureus the capacity to form a
biofilm in HHWm by a mechanism independent of the pres-
ence of the PNAG exopolysaccharide.
MATERIALS AND METHODS
Bacterial strains, culture conditions, and plasmids. The most relevant bacte-
rial strains and plasmids used in this study are listed in Table 1. Escherichia coli
XL1-Blue cells were grown in Luria-Bertani (LB) broth or on LB agar (Prona-
disa, Madrid, Spain) with appropriate antibiotics. Staphylococcal strains were
cultured using different media as indicated: Trypticase soy agar (TSA), Trypti-
case soy broth supplemented with glucose (TSBg) (0.25%, wt/vol), B2 medium
(1% casein hydrolysate, 2.5% yeast extract, 2.5% NaCl, 0.1% K2HPO4, and 0.5%
glucose [wt/vol]), and HHWm (Table 2). Biofilm-positive mutants were screened
on microtiter polystyrene plates using HHWm. Media were supplemented with
appropriate antibiotics at the following concentrations: erythromycin (Erm), 20
g ml1 or 1.5 g ml1; ampicillin, 100 g ml1; chloramphenicol, 20 g ml1;
kanamycin (Km), 50 g ml1; and tetracycline (Tet), 10 g ml1. When re-
quired, TSA was supplemented with X-Gal (Bioline, London, United Kingdom).
DNA manipulations. DNA plasmids were isolated from the E. coli strain using
the Bio-Rad plasmid miniprep kit (Bio-Rad Laboratories, Inc.) according to the
manufacturer’s protocol. Plasmids were transformed into staphylococci by elec-
troporation using a previously described protocol (13). Restriction enzymes were
purchased from Takara Shuzo Co. Ltd. or New England Biolabs and used
according to the manufacturer’s instructions. Oligonucleotides were obtained
from Life Technologies (see Table S1 in the supplemental material). For South-
ern hybridization, chromosomal DNA was purified, digested, and analyzed by
agarose gel electrophoresis. DNA fragments were transferred by alkaline capil-
lary blotting onto nylon membranes (Schleicher and Schuell) using standard
methods (5). Labeling of the probe and DNA hybridization were performed
according to the protocol supplied with the PCR-DIG DNA-labeling and chemi-
luminescence detection kit (Boehringer Mannheim). The agr, sarA, and atl genes
were inactivated in S. aureus ISP479r by transferring agr::tet, sarA::Km, and
atl::LacZ (Erm) from strains ISP479-agr, ISP479-sar (49), and SH108 (17), re-
spectively, by phage transduction using 85 (43).
Transposon mutagenesis and gene identification. The collection of 10,000
transposon mutants of S. aureus 15981 was generated from three independent
mutagenesis experiments in a previous work (49). To identify genes disrupted by
Tn917 insertions, chromosomal DNA of each mutant was digested with EcoRI
and religated in 200 l of ligation buffer (Promega) for 12 h at 14°C as previously
described (41). The ligation products were transformed into E. coli XL1-Blue
and selected on LB agar containing ampicillin. Plasmid DNA was extracted using
a Bio-Rad plasmid miniprep kit. Chromosomal DNA sequences flanking the
transposon were obtained using the primer pseq (see Table S1 in the supple-
mental material), which corresponds to the inverted repeat region located 70 bp
from the Erm-proximal end of Tn917. Nucleotide sequences were determined in
an ABI PRISM 310 genetic analyzer (Applied Biosystems). Homology searches
were carried out using the BLAST 2.0 program (1) at the NCBI server.
Disruption of TCS operons by insertion of the pBT2 plasmid. For disruption
of TCS1, -3, -4, -5, -11, -14, -16, and -17 in strain 15981 (Table 3), a PCR
fragment within the N-terminal regions of the different TCS amplified with
primers A and B (see Table S1 in the supplemental material) was cloned in the
pGEM-T Easy vector (Promega). The corresponding TCS fragment was then
cloned into the EcoRI site of the shuttle vector pBT2, and the resulting plasmid
(Table 1) was transformed into S. aureus by electroporation. After electropora-
tion, bacterial strains were incubated for 24 to 48 h at 30°C on TSA with
chloramphenicol. Ten milliliters of TSBg-chloramphenicol was subsequently in-
oculated with a single colony which had been previously resuspended in 100 l
of TSA broth, and the culture was incubated for 24 h at 44.5°C without shaking.
Tenfold serial dilutions of this culture in sterile TSBg were plated on TSA-
chloramphenicol and incubated for 24 h at 44.5°C. After overnight incubation,
the disruption of the respective TCS was confirmed by Southern blot analysis.
Allelic exchange of chromosomal genes. To construct the deletions of TCS6,
-7, -8, -9, -10, -12, -13, and -15 (Table 3), we amplified by PCR two fragments of
500 bp that flanked the sequences to the left (oligonucleotides A and B) and the
right (oligonucleotides C and D) of the sequence targeted for deletion (Table S1
in the supplemental material). Oligonucleotide C has at least a 16-base comple-
mentary region with oligonucleotide B to allow the products of the first PCR to
anneal. A second PCR was performed with primers A and D to obtain a single
fragment. Specifically, 1 l of each of the first PCR products was mixed with 10
pm of the outside primers and PCR amplified. The fusion products were purified
and cloned in the pGEM-T Easy vector (Promega). The fragments were then
cloned into the EcoRI site of the shuttle plasmid pMAD. To construct the
mutant allele to produce the ica deletion, the icaAB and icaCD PCR fragments
were cloned separately in the pGEM-T Easy vector (Promega), the plasmids
were digested with EcoRI and BamHI to purify both fragments, and finally, the
fragments were fused by ligation into plasmid pMAD. The resulting plasmids
(Table 1) were transformed into S. aureus by electroporation. pMAD contains a
temperature-sensitive origin of replication and an erythromycin resistance gene
(3). Homologous recombination experiments were performed as previously de-
scribed (49). Erythromycin-sensitive white colonies, which no longer contained
the pMAD plasmid, were tested by PCR using oligonucleotides A and D to
confirm the gene replacement. For the construction of a functional rsbU strain,
ISP479r (ISP479 rsbU), a 3-kb fragment encompassing the complete rsbU-rsbV-
rsbW region and part of sigB from plasmid pMAL30 (30), was digested with
EcoRI and BamHI and cloned into pMAD. The plasmid was integrated into the
chromosome through homology with the parental copy as previously described
(49), and the replacement was confirmed by PCR with primers rsbU-3 and rsbU-4
(Table S1 in the supplemental material).
Complementation experiments. The arlRS operon was amplified with thermo-
philic DNA polymerase (Certamp long amplification kit; Biotools, Spain) from S.
aureus 15981 with primers E and F (Table S1 in the supplemental material). The
PCR product was cloned into pCU1 (4), and the resulting plasmid, parlRS,
(Table 1) was transformed by electroporation into 15981 arlRS.
Biofilm formation assays. A biofilm formation assay in microtiter wells was
performed as described previously (29). To analyze biofilm formation under flow
conditions, we used 60-ml microfermentors (Pasteur Institute) (www.pasteur.fr
/recherche/unites/Ggb/biofilmfermenter.html) with a continuous flow of 40 ml of
chemically defined medium h1 and constant aeration with sterile pressed air.
Submerged Pyrex slides served as the growth substratum. Bacteria from an
overnight culture grown at 37°C with aeration in chemically defined media were
diluted to an optical density (OD) at 600 nm of 1. For the inoculation, the Pyrex
slides were introduced in the bacterial solution for 2 min and placed back in the
microfermentors. The microfermenters were cultivated for 24 h at 37°C. Biofilm
development was recorded with a Nikon Coolpix 950 digital camera. To quantify
the 24-h biofilm, bacteria that adhered to the surfaces of the Pyrex slides were
resuspended in 10 ml chemically defined medium. The OD of the suspension was
measured at 650 nm. Biofilm detachment assays with proteases and sodium
metaperiodate were carried out as previously described (34) except that 24-well
microtiter plates (Sarstedt; catalog no. 1836300) were used and the bacteria that
remained attached to the surface were stained with crystal violet, rewashed, and
destained with 1 ml of ethanol-acetone (80:20, vol/vol). A total of 200 l of the
ethanol-acetone-dye solution was transferred to a 96-well microtiter plate for
spectrophotometric analysis at 595 nm.
Confocal laser scanning microscopy. Overnight cultures of the 15981 and
arlRS strains carrying pSB2019, a plasmid that expresses green fluorescent
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TABLE 1. Strains and plasmids used in this study
Strain(s) or plasmid Relevant characteristic(s) Source orreferencea
S. aureus strains
15981 Clinical strain isolate; biofilm positive in TSBg 49
12313 Clinical strain isolate; biofilm positive CUN
V329 Bovine subclinical mastitis isolate; biofilm positive 13
7879 Clinical strain isolate; biofilm positive in TSBg CUN
49 Clinical strain isolate; biofilm positive in TSBg CUN
1246 Clinical strain isolate; biofilm positive in TSBg CUN
G-3320 Clinical strain isolate; biofilm positive in TSBg CUN
MM4, -7, -13, and -14 15981 arlS::Tn917 This study
MM11 and MM19 15981 arlR::Tn917 This study
15981 TCS-3 15981 pBT2 SA0214 gene insertional mutant This study
15981 TCS-4 15981 pBT2 lytS gene insertional mutant This study
15981 TCS-5 15981 pBT2 SA0614 gene insertional mutant This study
15981 saeRS 15981 with deletion of the saeRS genes This study
15981 TCS-7 15981 with deletion of the SA1158-SA1159 sequence This study
15981 arlRS 15981 with deletion of the arlRS operon This study
15981 srrAB 15981 with deletion of the srrAB genes This study
15981 TCS-10 15981 with deletion of the SA1515-SA1516 sequence This study
15981 TCS-11 15981 pBT2 SA1667 insertional mutant This study
15981 TCS-12 15981 with deletion of the vraSR genes This study
15981 agr 15981 with deletion of the agrBDCA genes 49
15981 TCS-14 15981 pBT2 SA1882 insertional mutant This study
15981 TCS-15 15981 with deletion of the SA2151-SA2152 sequence This study
15981 TCS-16 15981 pBT2 SA2180 insertional mutant This study
15981 TCS-17 15981 pBT2 SA2418 insertional mutant This study
15981 pCU1 15981 complemented with pCU1 This study
15981 arlRS pCU1 arlRS complemented with pCU1 This study
15981 arlRS parlRS arlRS complemented with the arlRS operon This study
15981 pSB2019 15981 complemented with the pSB2019 plasmid, which expresses GFP This study
15981 arlRS pSB2019 arlRS complemented with the pSB2019 plasmid, which expresses GFP This study
15981 ica 15981 with deletion of the icaADBC operon This study
15981 arlRS ica arlRS with deletion of the icaADBC operon This study
15981 sarA 15981 with deletion of the sarA gene 49
15981 arlRS sarA arlRS with deletion of the sarA gene This study
ISP479c ISP479 with rsbU deficiency. Cured of the pID258 plasmid 49
ISP479r ISP479c with rsbU restored This study
ISP479r arlRS ISP479r with a deletion of the arlRS operon This study
ISP479-sarA ISP479 sarA::Km 49
ISP479r-sarA ISP479r sarA::Km This study
ISP479r arlRS-sarA ISP479r arlRS sarA::Km This study
ISP479-agr ISP479 agr::tet 49
ISP479r-agr ISP479r agr::tet This study
ISP479r-agr arlRS ISP479r agr::tet with deletion of the arlRS operon This study
SH108 8325-4 atl::LacZ (Erm) 17
ISP479r-atl ISP479r atl::LacZ (Erm) This study
ISP479r arlRS-atl ISP479r arlRS atl::LacZ (Erm) This study
ISP479r-agr-atl ISP479r agr::tet atl::LacZ (Erm) This study
ISP479r-agr arlRS-atl ISP479r agr::tet arlRS atl::LacZ (Erm) This study
Plasmids
pMAD E. coli-S. aureus (Listeria) shuttle vector with the bgaB gene encoding a -galactosidase. Apr/Err 3
pMAD TCS6AD pMAD plasmid contained the mutant allele for the deletion of the saeRS genes This study
pMAD TCS7AD pMAD plasmid containing the mutant allele for deletion of the SA1158-SA1159 sequence This study
pMAD TCS8AD pMAD plasmid containing the mutant allele for deletion of the arlRS operon This study
pMAD TCS9AD pMAD plasmid containing the mutant allele for deletion of the srrAB genes This study
pMAD TCS10AD pMAD plasmid containing the mutant allele for deletion of the SA1515-SA1516 sequence This study
pMAD TCS12AD pMAD plasmid containing the mutant allele for deletion of the vraSR genes This study
pMAD TCS13AD pMAD plasmid containing the mutant allele for deletion of the agrBDCA genes 49
pMAD TCS15AD pMAD plasmid containing the mutant allele for deletion of the SA2151-SA2152 sequence This study
pBT2 E. coli-S. aureus shuttle vector with thermosensitive origin of replication for S. aureus 8
pBT2 TCS-1 pBT2 plasmid with an internal fragment of the yycF gene This study
pBT2 TCS-2 pBT2 plasmid with an internal fragment of the SA0067 sequence This study
pBT2 TCS-3 pBT2 plasmid with an internal fragment of the SA0214 sequence This study
pBT2 TCS-4 pBT2 plasmid with an internal fragment of the lytS gene This study
pBT2 TCS-5 pBT2 plasmid with an internal fragment of the SA0614 sequence This study
pBT2 TCS-11 pBT2 plasmid with an internal fragment of the SA1667 sequence This study
pBT2 TCS-14 pBT2 plasmid with an internal fragment of the SA1882 sequence This study
Continued on facing page
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protein (GFP) (Table 1), grown at 37°C with aeration were diluted 1:40 in a
four-well Lab-Tek II sterile-chambered borosilicate coverglass (Nalge Nunc In-
ternational). After 24 h of incubation at 37°C, the biofilm was directly monitored
using a Nikon D-Eclipse C1 confocal microscope with a Plan Apo 60A/1.40 Oil
Dic H objective. Images (512 by 512 pixels) from nine different microscopic fields
for each strain were acquired and analyzed with EZ-C1 software (Nikon). The
experiment was repeated three times.
PNAG detection. PNAG production in S. aureus strains was detected as de-
scribed previously (12). Overnight cultures in chemically defined media were
diluted 1:100 and grown for 3, 4.5, 6, 7.5, and 24 h. Two milliliters of each culture
was centrifuged, the weights of the pellets were determined, and the pellets were
resuspended in a proportional quantity of 0.5 M EDTA (pH 8.0) to obtain the
same density of each sample. Fifty microliters of cells was boiled for 5 min and
centrifuged to pellet them. Forty microliters of the supernatant was incubated
with 10 l of proteinase K (20 mg/ml; Sigma) for 30 min at 37°C. After the
addition of 10 l of Tris-buffered saline (20 mM Tris-HCl, 150 mM NaCl [pH
7.4]) containing 0.01% bromophenol blue, 5-l aliquots of 1/2, 1/5, and 1/25
dilutions were spotted on a nitrocellulose filter using a Bio-Dot microfiltration
apparatus (Bio-Rad), blocked overnight with 5% skim milk in phosphate-buff-
ered saline with 0.1% Tween 20, and incubated for 2 hours with an anti-S. aureus
PNAG antibody diluted 1:20,000 (40). Bound antibodies were detected with a
peroxidase-conjugated goat anti-rabbit immunoglobulin G antibody (Jackson
ImmunoResearch Laboratories, Inc., PA) diluted 1:10,000 and the Amersham
ECL Western blotting system using a Chemi-Doc apparatus (Bio-Rad).
Statistical analysis. The SPSS 12.0 program was used for the statistical anal-
ysis. A two-tailed Student t test was used to determine the differences in biofilm
thickness between the wild type and the arlRS mutant as determined by EZ-C1
software and also in the primary attachment assay. A nonparametric test (Mann-
Whitney U test) was used to assess significant differences in bacterial density
between the wild-type and arlRS strains’ recovery from the glass spatula of the
microfermentors. Differences were considered statistically significant when P was
	0.05 in all cases.
RESULTS
Development of a chemically defined medium to study the S.
aureus biofilm formation process. It has been previously de-
scribed that the clinical S. aureus 15981 strain is capable of
producing strong biofilms in TSBg or B2 medium, indicating
that the machinery required for biofilm formation is fully func-
tional in this strain (49). To get further insight into the effect of
the growing media on the biofilm development of 15981, we
decided to study the biofilm development of this strain in a
modified version of the chemically defined medium previously
developed by Hussain et al. (31) (Table 2). We named the
medium HHWm. Unexpectedly, we found that S. aureus 15981
was unable to produce a biofilm in HHWm, suggesting either
that HHWm has nutritional restrictions or that HHWm lacks
an activating factor to support biofilm formation or that bio-
film formation is repressed in this medium. To answer this
question, the biofilm-forming capacity of eight genetically un-
related S. aureus strains in HHWm was assayed in the classical
microtiter plate assay. Figure 1 shows that only two strains,
12313 and V329, were able to produce biofilms after 24 h,
despite the fact that all selected strains produced biofilms in
TABLE 1—Continued
Strain(s) or plasmid Relevant characteristic(s) Source orreferencea
pBT2 TCS-16 pBT2 plasmid with an internal fragment of the SA2180 sequence This study
pBT2 TCS-17 pBT2 plasmid with an internal fragment of the SA2418 sequence This study
pCU1 Vector for complementation experiments. Apr Cmr 4
parlRS pCU1 plasmid containing arlRS operon This study
pMAL30 3-kb OL-80–OL-81 rsbU rsbV rsbW sigB PCR fragment in pAZ106 30
pMAD rsbU pMAD plasmid containing the 3-kb fragment encompassing the complete rsbU-rsbV-rsbW region
and part of sigB from plasmid pMAL30
This study
pMAD ica pMAD plasmid containing the mutant allele for deletion of the icaADBC operon This study
pMAD sarAD pMAD plasmid containing the mutant allele for deletion of the sarA gene 49
pSB2019 Translationally enhanced gfp-3 under the control of PxylA, with the xylR repressor removed to
give xylose-independent expression. Apr Cmr
44
a CUN, Clı´nica Universitaria de Navarra (University Clinic of Navarre, Spain).
TABLE 2. Compositions of chemically defined HHWm
Ingredient(s)a Volb Final concn(mg/liter)
Sterile MilliQ water 710
Solution A (10) 100
Na2HPO4 · 2H2O 8,950
KH2PO4 3,000
(NH4)2SO4 2,000
Solution B (50) 20
MgSO4 · 7H2O 50
MnSO4 · H2O 3.8
FeSO4 · 7H2O 2.8
Solution C (50) 20
Glucose 10,000
Solution D (100) 10
Biotin 0.1
Nicotinic acid 2
D-Panthothenic acid, Ca salt 2
Pyridoxyne hydrochloride (vitamin B6) 4
Riboflavin 2
Thiamine hydrochloride (vitamin B1) 2
Solution adenine (100) 50
Adenine · 1/2 H2SO4 3
Solution guanine (100) 50
Guanine · 1/2 H2SO4 4
Solution trace elements (20) 10
CaCl2 · 2H2O 7.28
ZnCl2 1.70
CuCl2 · 2H2O 0.43
CoCl2 · 6H2O 0.60
Na2MoO4 · 2H2O 0.60
Solution amino acids (50)c 20
Solution glutamine (100) 10
Glutamine 292
Solution Ca (100) 0.14
CaCl2 · 2H2O 735
a The solutions are listed in the order they are aggregated to the sterile water.
b Milliliters of each solution to prepare 1 liter of HHWm.
c RPMI 1640 amino acids solution without L-glutamine (Sigma; catalog no.
R7131).
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TSBg (Fig. 1A and B) and exhibited similar growth rates in
HHWm (data not shown). These results strongly suggest that
the biofilm-negative phenotype of most S. aureus strains in
HHWm, including the 15981 strain, is not due to nutritional
restrictions.
Biofilm formation capacity in HHWm of mutants in two-
component systems. Two-component systems are principal sig-
nal transducers involved in environmental sensing. We hypoth-
esized that any of the 17 two-component systems identified in
the genome of S. aureus N315 might be responsible for the
repression of the biofilm formation of strain 15981 in HHWm.
The SA0066-SA0067 TCS present in the genome of strain
N315 is contained in the SCCmec (the staphylococcal chromo-
somal cassette involved in methicillin resistance) and, conse-
quently, is not present in the methicillin-susceptible
NCTC8325, COL, MW2, or MSSA467 strain. Clinical strain
15981 is methicillin susceptible, and the absence of the
SA0066-SA0067 TCS was verified by PCR and Southern blot
analysis. Thus, we generated isogenic derivatives of 15 out of
the 16 TCS of S. aureus either by insertional inactivation or
gene replacement by allelic exchange in strain 15981 (see Ma-
terials and Methods) (Table 3). We were unable to generate
strains with mutations in yycFG, which has been shown to be
essential for the viability of S. aureus (39). All the resulting
TCS mutants exhibited growth rates in HHWm that were in-
distinguishable from those of the wild type. The analysis of the
biofilm formation capacity of the TCS mutants in HHWm
revealed that deletion of arlRS provoked an increase in biofilm
development (Fig. 2A). These results support our hypothesis
that the biofilm formation phenotype is repressed in HHWm
and that at least one TCS is involved in the process.
Random screening for repressors of the biofilm formation
process of S. aureus 15981 in HHWm. A second approach was
used to identify repressors of the biofilm formation process of
S. aureus 15981 in HHWm, based on the screening of a col-
lection of strains with approximately 10,000 transposon muta-
tions (49) to look for mutants that had gained the capacity to
produce a biofilm on microtiter polystyrene plates in HHWm.
Nine transposon mutants, exhibiting growth rates indistin-
guishable from the wild type, were found to acquire biofilm
formation capacity in HHWm (Fig. 2B). Sequencing of regions
adjacent to the transposon insertion site and homology
searches using the BLAST 2.0 program at the NCBI server
showed that, in six out of nine mutants, the transposon inser-
tion site was localized in four different positions of the arlS
gene (MM4, -7, -13, and -14) and in two different positions of
TABLE 3. Schematic representation of all the TCS of S. aureus and the biofilm formation ability of the corresponding
mutants in HHWm
TCSa Gene(s) or locustagsb Operon organization
c Mutation
typed
Biofilm in
HHWme Reference(s)
1 yycFGf NO ND 39
2 SA0067-SA0066g NO ND
3 SA0217-SA0215  
4 lytSR   9
5 SA0613-SA0615  
6 saeRS   20
7 SA1156-SA1159  
8 arlRS   18
9 srrAB srhAB   47, 53
10 SA1516-SA1515  
11 SA1667-SA1666  
12 vraSR   35
13 agrBDCA   32
14 SA1882-SA1883  
15 SA2151-SA2152  
16 SA2182-SA2179  
17 SA2419-SA2417  
a Numbers are based on the Staphylococcus aureus N315 sequence (36).
b Names of genes are based on S. aureus N315 (36) or according to the first reference where the TCS is described in the text.
c Schematic representation of the TCS, including the genes that belong to the same operon. Black arrows represent a response regulator gene, gray arrows represent
a histidine kinase sensor protein, and white arrows represent any gene in the operon.
d NO, no obtained mutant; , pBT2 insertional mutation; , deletion mutant.
e Biofilm formation ability in HHWm in microtiter plates. ND, not determined; , positive biofilm; , negative biofilm.
f Essential genes.
g The TCS is absent in the S. aureus 15981, NCTC8325, COL, MW2, and MSSA476 strains.
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the arlR gene (MM11 and MM19). The arlR/arlS transposon
mutants, akin to the arlRS strain, showed an increase in their
biofilm formation capacity in HHWm (Fig. 2C). The loci in-
terrupted by the transposon in the remaining three mutants
were lysA (MM1), odhA (MM15), and the intergenic region
SA1243-SA1244 (MM2). The role of these genes in the repres-
sion of biofilm development in HHWm is under study.
Although the finding that both approaches coincided in the
arlRS two-component system is strong evidence to conclude
that arlRS negatively affects biofilm formation in HHWm, we
complemented the arlRS strain with a plasmid carrying a copy
of the arlRS operon, including its own promoter region (see
Materials and Methods for details). This plasmid (parlRS) and
the vector control (pCU1) were introduced into the wild-type
and arlRS mutant strains, and their biofilm formation capacity
was analyzed. The results of the complementation analysis are
shown in Fig. 2D. When parlRS was introduced into the arlRS
mutants, inhibition of biofilm formation was observed, whereas
the vector control (pCU1) had no effect on biofilm formation
in either the wild type or the arlRS mutant.
arlRS is involved in an early stage of biofilm development.
An initial adhesion defect could have been the underlying
cause of the wild-type strain’s failure to form a biofilm in
HHWm. Therefore, we tested whether 15981 arlRS adhered
to polystyrene petri dishes under static conditions more effi-
ciently than the corresponding wild-type strain. Quantification
of adherent bacterial cells on a phase-contrast microscope
showed that the numbers of attached cells were significantly
higher in the case of the arlRS strains than that of the wild-
type strain (n 
 30; P 	 0.001, Student’s t test) (data not
shown). This result indicates that genes regulated by arlRS are
at least involved in the early attachment of S. aureus to abiotic
surfaces.
Biofilm formation of the arlRS mutant under flow cell con-
ditions. Since no fresh medium is provided during biofilm
FIG. 1. Biofilm formation ability of natural isolates of S. aureus in
HHWm. (A) Biofilm formation by S. aureus strains on microtiter plates
in HHWm and TSBg after 24 h of incubation at 37°C. The results of a
representative experiment are shown. (B) Quantification of the biofilm
formation capacity. The bacterial cells were stained with crystal violet
and were quantified by dissolving the dye in ethanol-acetone (80:20),
and the absorbance was determined at 595 nm. Data represent the
averages of results from 12 wells from three different plates. The
vertical line at the top of the each bar represents a standard deviation.
FIG. 2. Biofilm formation phenotype of biofilm-positive mutants
on microtiter plates in HHWm. (A) Biofilm formation phenotype of
wild-type 15981 and isogenic mutants in all the TCS on microtiter
plates grown in HHWm at 37°C for 24 h (Table 3). (B) Biofilm
formation phenotype of wild-type and selected biofilm-positive mu-
tants on microtiter plates grown in HHWm at 37°C for 24 h. Tn917 was
inserted in different positions of the arlS gene in mutants MM4, -7, -13,
and -14 and two different positions of the arlR gene in MM11 and
MM19. (C) Biofilm formation phenotype of the arlRS mutant com-
pared to the wild-type strain and insertional transposon mutants.
(D) Biofilm formation phenotype of the wild-type and arlRS mutant
strains complemented with either the parlRS plasmid carrying the
arlRS operon under the control of its own promoter or the pCU1
plasmid. HHWm was supplemented with 20 g/ml of chloramphenicol.
The results of a representative experiment are shown.
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development on a microtiter plate, nutrient concentration de-
clines and the concentration of waste products increases
throughout the incubation period. Since any or both of these
factors could represent the input signal for the activation of the
arlRS two-component system and the ensuing inhibition of
biofilm development in HHWm, we used microfermentors
where nutrients were continually replenished to compare the
biofilm development of wild-type and arlRS mutant strains.
Both macroscopic biofilm development in microfermentors
and biofilm cell density on the removable glass slides of the
fermentors were examined. The data in Fig. 3 show that 15981
arlRS displayed a robust biofilm phenotype. It is worth noting
that wild-type bacteria displayed substantial biofilm develop-
ment in the microfermentors in comparison to that of the
phenotype shown on microtiter plates, suggesting that limited
aeration and/or nutrient depletion and/or accumulation of
waste products during steady-state incubation conditions also
have a negative effect on strain 15981’s biofilm development.
However, the fact that the absence of arlRS still enhanced
biofilm formation in microfermentors (n 
 3; P 	0.05) sug-
gests that arlRS-mediated repression of biofilm development is
also effective under these conditions.
Biofilm architecture of arlRS mutants. Biofilms formed by
the 15981 and arlRS strains in HHWm were examined by
confocal laser scanning microscopy. Cells expressing the GFP
were incubated overnight at 37°C as a static culture in a four-
well Lab-Tek II chamber slide system (Nalge Nunc Interna-
tional). Since the biofilms produced by arlRS mutants did not
tightly attach to the polystyrene surface and were easily dis-
rupted when rinsed, bacterial structures attached to the cov-
erslip were directly observed by confocal laser scanning mi-
croscopy (Fig. 4A). The biofilm formed by the arlRS strain
appeared to consist of microcolonies of bacterial cells sepa-
rated by interstitial voids (medium-filled channels). This was in
contrast to what occurred with the wild-type strain, which cov-
ered the surface uniformly and lacked a three-dimensional
architecture, strongly suggesting that these bacteria corre-
spond to the normal sedimentation process that occurred dur-
ing the incubation period at the bottom of the chamber. We
used the EZ-C1 software to quantify the thickness of the bio-
film. In agreement with the microtiter dish assays and the
visual impression, the value for total thickness was significantly
increased (n 
 27; P 	 0.0001) in the case of the arlRS mutant
strain compared with that of the wild-type strain (Fig. 4B).
PNAG is not required for the biofilm development promoted
by the arlRS mutation. It has been shown that PNAG produc-
tion is essential for the biofilm development of S. aureus. To
investigate whether PNAG production was altered in 15981
arlRS, the level of PNAG was monitored by dot blotting using
specific anti-PNAG polyclonal antisera. The results showed
that PNAG production in 15981 arlRS was enhanced at all
phases of growth in HHWm compared to the PNAG produc-
tion of the parental strain (Fig. 5A). The fact that 15981 pro-
duced detectable amounts of PNAG indicates that arlRS is
relevant but not essential for PNAG production. These results
suggest that, in addition to a higher level of primary attach-
ment, the enhancement in biofilm formation presented by the
arlRS mutant may be attributable to an increase in PNAG
levels.
To unambiguously demonstrate that enhanced accumulation
of PNAG was directly related to the enhanced biofilm devel-
opment of arlRS mutants, we produced a nonpolar deletion of
the icaADBC operon in the arlRS mutant. Surprisingly, the
resulting double arlRS icaADBC mutant retained the capacity
to produce biofilm in HHWm, whereas the ability to produce
biofilm in TSBg was completely abolished (Fig. 5B). These
results indicated that PNAG, in contrast to its essential role in
the biofilm matrix produced in TSBg, is dispensable for the
biofilm promoted by the arlRS mutation in HHWm.
To determine whether the biofilm produced by the arlRS
mutant was mediated by another exopolysaccharide or a sur-
face adhesin, biofilm detachment experiments were carried out
with proteinase K, pronase, and sodium metaperiodate (a car-
bohydrate-modifying agent). The results showed that the bio-
film induced by the arlRS strain was sensitive to detachment
by proteases and resistant to sodium metaperiodate (Fig. 5C).
These results are consistent with our finding that PNAG is not
required for the arlRS mutant biofilm formation process and
strongly suggest that a proteinaceous compound might be re-
sponsible for biofilm development in the arlRS mutant.
SarA is essential for the biofilm development promoted by
the arlRS mutation. Previous studies have described that the
arl mutation decreased sarA transcription and increased the
synthesis of RNA III (19). In addition, others and we have
found that SarA is essential for the biofilm development of S.
aureus (6, 49) and S. epidermidis (48). To investigate the role of
SarA in the biofilm produced by the arlRS mutant, the sarA
gene was deleted in the arlRS strain. Interestingly, the double
arlRS sarA mutant lost the capacity to produce biofilm in both
FIG. 3. Biofilm formation phenotype of the wild-type and arlRS
strains in microfermentors. (A) Biofilm development of bacteria grown
under continuous-flow conditions with HHWm after 24 h at 37°C. The
microfermentors (upper panels) contain the glass slides where bacteria
form the biofilm (lower panels). The results of a representative exper-
iment are shown. (B) Quantification of the biofilms adhered to the
glass slides. The cells were removed from the glass slides into 10 ml of
HHWm by using a vortex, and the OD of the resulting solution was
measured at 650 nm. Significant differences were detected between the
wild-type and the arlRS mutant (n 
 3; P 	 0.05, Mann-Whitney U
test).
5324 TOLEDO-ARANA ET AL. J. BACTERIOL.
 o
n
 January 10, 2019 by guest
http://jb.asm.org/
D
ow
nloaded from
 
FIG. 4. Effect of an arlRS mutation on biofilm architecture. S. au-
reus 15981 and 15981 arlRS strains harboring plasmid pSB2019 to
provide constitutive GFP expression were grown in a four-well Lab-
Tek II chamber with HHWm at 37°C for 24 h. (A) Biofilm develop-
ment was monitored by scanning confocal laser microscope. The pan-
els on the left are an overlay of multiple slices, and the side frames of
the panels on the right are the z planes, which show the thickness of the
biofilm and the architecture as viewed from the cross section. The line
on the z plane indicates the level at which the photograph of the x-y
plane was taken. Photographs were taken at a magnification of 600.
The results of a representative experiment are shown. (B) Quantifica-
tion of the biofilm thickness using EZ-C1 software. Data represent the
averages of results from 27 different fields from three independent
experiments. The vertical line at the top of each bar represents the
standard deviation. The asterisk represents a statistically significant
difference (P 	 0.0001, Student’s t test).
FIG. 5. (A) Dot blot analysis of PNAG accumulation in the wild-
type strain and its corresponding arlRS mutant at different points of
the growth curve. Cell surface extracts at different times were treated
with proteinase K, and dilutions of the extracts (1/2, 1/5, and 1/25) were
spotted onto nitrocellulose membranes. PNAG production was de-
tected with an anti-S. aureus PNAG antiserum. The arlRS mutant
produced higher levels of PNAG product at all points of the growth
curve. The results of a representative experiment are shown. (B) Bio-
film formation phenotype of the 15981, arlRS, ica, and arlRS ica
strains grown in TSBg and HHWm on microtiter plates. After 24 h of
incubation, the microplates were washed and stained with crystal vio-
let. The dye was dissolved by the addition of 200 l of ethanol-acetone
(80:20). The results of a representative experiment are shown. (C) Bio-
film detachment assays. Biofilms of the 15981, arlRS, ica, and
arlRS ica strains grown in HHWm for 16 h were treated for 2 h at
37°C with 10 mM sodium metaperiodate or with 100 g of proteinase
K or pronase. The bacteria that remained attached to the surface were
stained with crystal violet. The dye was dissolved by the addition of 200
l of ethanol-acetone (80:20). The results of a representative experi-
ment are shown. ON, overnight; WT, wild type.
VOL. 187, 2005 ica-INDEPENDENT BIOFILM DEVELOPMENT IN S. AUREUS 5325
 o
n
 January 10, 2019 by guest
http://jb.asm.org/
D
ow
nloaded from
 
HHWm and TSBg, indicating that SarA is epistatic to the
arlRS mutation in that the double mutant resembled the sarA
single mutant with respect to its inability to form biofilm (Fig.
6A). To confirm the independence of the biofilm-deficient
phenotype with respect to the strain background, we also pro-
duced nonpolar mutations of arlRS, sarA, and arlRS sarA in
strain ISP479r, a derivative of 8325-4 in which the 11-nucleo-
tide deletion of the rsbU gene has been restored by allelic
exchange. Consistent with the results observed in strain 15981,
the mutation of arlRS in strain ISP479r promoted biofilm de-
velopment in HHWm (Fig. 6A), whereas the arlRS sarA double
mutant displayed a phenotype indistinguishable from that of
the wild-type strain.
Several studies with contradictory results have related the
agr quorum-sensing system with the biofilm formation process
of S. aureus. The discrepancies of the results might be ex-
plained by the possibility that the role of agr expression in
biofilm development is dependent upon the conditions under
which the biofilm was grown (52). To determine whether agr
was involved in the biofilm produced by the arlRS mutant in
HHWm, we produced the deletion of agr and arlRS agr in S.
aureus ISP479r. We used this strain because during the course
of this study, we noticed that the clinical strain 15981 has a
natural mutation of the agr system (M. Otto, personal commu-
nication). The ISP479r-agr strain, which would be equivalent to
the 15981 strain, displayed a biofilm formation phenotype in-
distinguishable from that of the wild-type strain ISP479r in
HHWm and TSBg (Fig. 6B). Interestingly, disruption of arlRS
in the agr mutant reproducibly resulted in increased biofilm
development in comparison to that of the single arlRS mutant.
These results suggest that agr mutation alone has no effect on
the biofilm formation capacity of S. aureus in HHWm. How-
ever, since the combination of agr and arlRS mutations rein-
forced biofilm development in HHWm, the results also suggest
that both arlRS and agr play a negative role in biofilm devel-
opment in HHWm.
Increased autolysin activity is not responsible for biofilm
development in HHWm. It has been described previously that
an arlS mutant exhibited increased autolysis and altered pep-
tidoglycan hydrolase activity (18). To rule out the possibility
that the increased biofilm development of the arlRS mutant in
HHWm was due to an increased autolysin activity, the atl gene
was deleted in wild-type ISP479r and the corresponding
ISP479r arlRS, ISP479r-agr, and ISP479r agr arlRS strains.
No differences between the wild-type and the corresponding
mutants were observed (Fig. 7), indicating that the activity of
the major autolysin was not responsible for the biofilm en-
hancement of the arlRS mutant.
DISCUSSION
S. aureus is a ubiquitous bacterium, able to exist on inani-
mate objects as well as in a variety of niches of the human or
animal host, such as the skin, mucous membranes, blood,
bones, and mammary glands. These locations are not hermetic,
and during its lifetime, a single bacterium can travel from one
location to another. These transitions are very likely to require
quick switches from a unicellular planktonic existence to the
settled multicellular communities commonly referred to as bio-
films. This versatility depends on a complex regulatory network
responsible for sensing and responding to the environmental
conditions that favor biofilm formation or the release of bac-
teria from the biofilm to colonize new niches.
In this study, we present evidence that the two-component
regulatory system arlRS negatively affects the biofilm forma-
tion of S. aureus. These results are consistent with a previous
study showing that arlS mutation induced biofilm formation on
a polystyrene surface in a complex TSB medium (18). In the
same report, it was shown that biofilm formation was associ-
ated with an enhanced primary attachment probably owing to
an increased autolysin activity. However, in contrast to this
FIG. 6. Effects of the mutation of sarA and agr regulators on the
biofilm promoted by an arlRS mutation. Bacteria were inoculated onto
microtiter plates containing TSBg and HHWm. After 24 h of incuba-
tion, the microplates were washed and stained with crystal violet. The
dye was dissolved in 200 l of ethanol-acetone (80:20). The results of
a representative experiment are shown. (A) Comparison of biofilm
formations by S. aureus 15981 and ISP479r and their corresponding
arlRS, sarA, and arlRS sarA mutants in HHWm and TSBg.
(B) Comparison of biofilm formations by S. aureus strains 15981, 15981
arlRS, ISP479r, and ISP479r’s corresponding mutant derivatives
ISP479r arlRS, ISP479r-agr, and ISP479r-agr arlRS in HHWm and
TSBg. WT, wild type.
FIG. 7. Effects of the mutation of atl on the biofilm promoted by an
arlRS mutation. Comparison of biofilm formations by strain ISP479r
and its corresponding ISP479r arlRS, ISP479r-atl, and ISP479r
arlRS-atl mutant derivatives and by the same mutants constructed in
the ISP479r agr null background. Bacteria were inoculated onto mi-
crotiter plates containing TSBg and HHWm. After 24 h of incubation,
the microplates were washed and stained with crystal violet. The dye
was dissolved in 200 l of ethanol-acetone (80:20). The results of a
representative experiment are shown.
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hypothesis, our results indicate that autolysin activity is not
responsible for the biofilm enhancement observed in an arlRS
mutant, because a mutation in the atl gene, which encodes the
main autolysin of S. aureus, did not restore the phenotypes of
wild-type bacteria.
Apart from Atl, another candidate that we needed to take
into consideration in relation to the biofilm development of S.
aureus was the exopolysaccharide PNAG. It has been demon-
strated that disruption of the icaADBC operon responsible for
the synthesis of PNAG impairs the biofilm development of
most of the S. aureus strains analyzed to date (21, 49). Based
on that demonstration, PNAG has been considered an essen-
tial compound of the biofilm matrix of S. aureus. On the con-
trary, the results of the present study indicate that arlRS reg-
ulates a mechanism of biofilm development independent of
PNAG accumulation. This alternative mechanism is being sup-
ported by an increasing amount of evidence (7, 14). First, in an
earlier work, we showed that disruption of the ica operon in a
bovine mastitis bap-positive strain had no effect on in vitro
biofilm formation, a finding which strongly suggested that the
Bap protein could compensate for the deficiency of PNAG
(14). It is important to note that this bovine strain, V329, is one
of the strains capable of producing biofilm in HHWm (see Fig.
1). Second, Beenken et al. also demonstrated that deletion of
the icaADBC operon in the clinical S. aureus UAMS-1 strain
had little impact on biofilm formation both in vivo and in vitro
(7), though the mechanism for biofilm formation of this strain
was not determined. In an attempt to explain the PNAG-
independent mechanism shown in the current study, we estab-
lished that it was not dependent on the presence of Bap, since
we were not able to detect any Bap-homologous protein in the
15981 or ISP479 strain (data not shown). Fournier et al. de-
termined that one of the most remarkable consequences of the
arlS mutation was the dramatic decrease in extracellular pro-
teolytic activity (18). Accordingly, and given that surface pro-
teins could initiate primary attachment to the surface or par-
ticipate in intercellular adhesion, it is likely that the absence of
extracellular proteases in 15981 arlRS and ISP479r arlRS
could facilitate the accumulation of one or more proteins that
would mediate the attachment to surfaces. In this scenario,
disruption of sarA in such mutants abolished biofilm develop-
ment. This could be the result of the restoration of the secre-
tion of the main extracellular proteases and promotion of
bacterial dissemination by cleavage of bacterial attachment
proteins. Another consequence of the absence of extracellular
proteases in arlRS mutants might be the preservation of Ica
proteins from degradation, which would allow the accumula-
tion of PNAG. Our data indicated that the arlRS mutant ac-
cumulated higher levels of PNAG than the wild-type strain,
whereas the transcriptional levels of the icaADBC operon in
the mutant were similar to or were up-regulated at the postex-
ponential phase of growth in comparison to the corresponding
levels of the wild-type strain (our unpublished results). A sim-
ilar discrepancy between the accumulation of polysaccharide
intercellular adhesin/PNAG and the transcription of the
icaADBC operon has also been described for S. epidermidis
growing in the presence of glucose (15). This is due to the fact
that under these conditions, S. epidermidis exhibited polysac-
charide intercellular adhesin and a biofilm-positive phenotype,
whereas ica transcription was down-regulated. Altogether, it
seems as though as soon as enough PNAG is accumulated,
bacteria may repress the synthesis of Ica proteins by some kind
of negative-feedback regulatory mechanism. Besides the effect
of arl on the accumulation of extracellular proteases, we can-
not rule out the possibility that arlRS could directly repress the
expression of an adhesin or some other effector protein that is
required for biofilm formation. Alternatively, arlRS could also
activate the expression of a factor whose presence could be
deleterious for biofilm formation.
In this study, we have also performed the systematic disrup-
tion of 15 two-component regulatory systems in the same strain
of S. aureus. yycGF was the only TCS in which we were unable
to generate an insertional mutation, confirming that this TCS
is essential for S. aureus (16, 39). The remnant TCS were not
essential for the survival of S. aureus, and examination of the
growth curves of TCS mutants in HHWm did not show signif-
icant differences among them. It is noteworthy that we have
unintentionally constructed all our isogenic mutants in the
two-component systems in an agr null genetic background,
which occurs quite frequently in natural isolates of S. aureus
(51). Since the functionality of 9 out of 16 of the TCS of S.
aureus is completely unknown, it is impossible to predict how
the absence of a functional agr gene might affect their expres-
sion. The finding that a single mutation of agr has no effect on
the biofilm formation of strains 15981 and ISP479r indicates
that agr is not responsible for the biofilm enhancement of the
arlRS mutant. The strength of the biofilm observed in the
double mutant ISP479r arlRS agr could be due to the deter-
gent-like physicochemical properties of the delta-hemolysin
(50) whose gene is carried within the gene for RNA III, and its
expression is therefore directly linked to agr activity (32). Nev-
ertheless, the roles of agr and quorum sensing in biofilm for-
mation remain elusive. Recently, Yarwood et al. observed that
the influence of agr on biofilm formation ranged from an en-
hanced effect or no discernible effect to impaired biofilm de-
velopment, depending on the conditions of the experiments
(52). They interpreted these results as indicating that the wide
range of genes regulated by agr could influence S. aureus at-
tachment and biofilm development under some conditions but
not others.
Recently, in an effort to identify the potential function of
each TCS in the biology of a clinical isolate of Enterococcus
faecalis, systematic inactivation of 17 out of 18 TCS was carried
out (26). Only one of the TCS, fsrABC, displayed a deficiency
in biofilm formation (25). The fsrABC locus is a quorum-
sensing system that belongs to the so-called agr-like subfamily
of two-component signal transduction systems characterized by
the presence of a third component, a secreted signaling pep-
tide. Hancock and Perego (25) concluded that disruption of fsr
provokes a deficiency in a zinc-metalloprotease gelatinase
which is required for the formation of biofilm by a still-un-
known mechanism. None of the TCS mutants we constructed
showed any deficiency on biofilm formation in rich media, and
apparently there is no resemblance between the role of fsr in E.
faecalis and the role of the corresponding TCS of S. aureus in
the regulation of biofilm development, suggesting the existence
of a species-specific biofilm formation process in gram-positive
bacteria.
While there is little doubt that there exist other S. aureus
genes critical for biofilm development yet to be discovered, our
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results suggest that the regulatory network for biofilm forma-
tion is more complex than first anticipated and includes posi-
tive and negative regulators. In this regard, this work also
indicates that screening for mutants that gain biofilm forma-
tion capacity in microtiter dishes could be useful for the iden-
tification of those genes that have negative consequences in the
bacterial-biofilm formation process.
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